RenovoRx Inc (RNXT) has a current Price-to-Book (P/B) ratio of 3.79. Compared to its 3-year average P/B ratio of 157.14, the current P/B ratio is approximately -97.59% higher. Relative to its 5-year average P/B ratio of 102.61, the current P/B ratio is about -96.31% higher. RenovoRx Inc (RNXT) has a Forward Free Cash Flow (FCF) yield of approximately -33.97%. Compared to its 3-year average FCF yield of -41.71%, the current FCF yield is approximately -18.57% lower. Relative to its 5-year average FCF yield of -37.88%, the current FCF yield is about -10.33% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for RNXT competitors is 5.64, providing a benchmark for relative valuation. RenovoRx Inc Corp (RNXT.O) exhibits a P/S ratio of 12.74, which is 125.83% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of RNXT increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of RNXT in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is RNXT currently overvalued or undervalued?

What is RenovoRx Inc (RNXT) fair value?

RNXT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of RenovoRx Inc (RNXT) is between 0.77 to 1.82 according to relative valuation method.

How does RNXT's valuation metrics compare to the industry average?

The average P/S ratio for RNXT's competitors is 5.64, providing a benchmark for relative valuation. RenovoRx Inc Corp (RNXT) exhibits a P/S ratio of 12.74, which is 125.83% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for RenovoRx Inc (RNXT) as of Mar 03 2026?

As of Mar 03 2026, RenovoRx Inc (RNXT) has a P/B ratio of 3.79. This indicates that the market values RNXT at 3.79 times its book value.

What is the current FCF Yield for RenovoRx Inc (RNXT) as of Mar 03 2026?

As of Mar 03 2026, RenovoRx Inc (RNXT) has a FCF Yield of -33.97%. This means that for every dollar of RenovoRx Inc's market capitalization, the company generates -33.97 cents in free cash flow.

What is the current Forward P/E ratio for RenovoRx Inc (RNXT) as of Mar 03 2026?

As of Mar 03 2026, RenovoRx Inc (RNXT) has a Forward P/E ratio of -2.18. This means the market is willing to pay $-2.18 for every dollar of RenovoRx Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for RenovoRx Inc (RNXT) as of Mar 03 2026?

As of Mar 03 2026, RenovoRx Inc (RNXT) has a Forward P/S ratio of 12.74. This means the market is valuing RNXT at $12.74 for every dollar of expected revenue over the next 12 months.

RNXT Valuation